Lowell Therapeutics: Funding, Investors & Team (Oct 2026)
Lowell Therapeutics is a pharmaceutical company that develops products for critically ill patients. It develops an anticoagulant for critically ill patients in the ICU who experience kidney failure and need to go on an artificial kidney machine called continuous renal replacement therapy (CRRT), which is 24/7 dialysis. This machine involves circulating blood outside the patient through a filter. Eventually, blood will clot in the filter unless it is anticoagulated. When the filter clogs, doctors and nurses must stop the machine to change it – throwing away clotted blood and in the process, increasing blood loss and the need for transfusions.
Lowell Therapeutics has raised $4.0M across 1 funding round on record, the most recent a Seed of $4.0M announced in Oct 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lowell Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2021.
Lowell Therapeutics Funding Rounds
Lowell Therapeutics Founders and Leadership Team
Contact details for the Lowell Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Lowell Therapeutics Funding Compared to Other Biotechnology Startups
Lowell Therapeutics' latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lowell Therapeutics in Biotechnology and Lowell
Companies Similar to Lowell Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Lowell Therapeutics Funding FAQs
What does Lowell Therapeutics do?
Lowell Therapeutics is a pharmaceutical company that develops products for critically ill patients. It develops an anticoagulant for critically ill patients in the ICU who experience kidney failure and need to go on an artificial kidney machine called continuous renal replacement therapy (CRRT), which is 24/7 dialysis. This machine involves circulating blood outside the patient through a filter. Eventually, blood will clot in the filter unless it is anticoagulated. When the filter clogs, doctors and nurses must stop the machine to change it – throwing away clotted blood and in the process, increasing blood loss and the need for transfusions.
How much funding has Lowell Therapeutics raised?
Lowell Therapeutics has raised $4.0M across 1 round on record. The most recent is a Seed of $4.0M announced in Oct 2021.
When did Lowell Therapeutics last raise funding?
Lowell Therapeutics' most recent funding round on record is a Seed of $4.0M, announced in Oct 2021.
Who is the CEO of Lowell Therapeutics?
Jim Wilkie is listed as CEO at Lowell Therapeutics.
Where is Lowell Therapeutics headquartered?
Lowell Therapeutics is based in Lowell, Massachusetts, United States.
How many employees does Lowell Therapeutics have?
Lowell Therapeutics is in the 1-10 employee band.
How does Lowell Therapeutics' funding compare to other Biotechnology startups?
Lowell Therapeutics' latest round of $4.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Lowell Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lowell Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.